Prot #5F9009: ENHANCE: A Randomized, Double-blind, Multicenter Study Comparing Magrolimab in Combination with Azacitidine versus Azacitidine Plus Placebo in Treatment-naïve Patients with Higher Risk Myelodysplastic Syndrome

Project: Research project

Project Details

StatusActive
Effective start/end date8/18/208/18/23

Funding

  • ICON Clinical Research, LLC (Prot #5F9009)
  • Forty Seven, Inc. (Prot #5F9009)